Insufficient scRNA-seq data for expression of CBS at single-cell level.
Insufficient scRNA-seq data for expression of CBS at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 90% | 269.99 | 2379 / 2642 | 82% | 3.33 | 576 / 705 |
liver | 96% | 1130.39 | 217 / 226 | 67% | 2.45 | 271 / 406 |
prostate | 88% | 221.36 | 215 / 245 | 63% | 1.93 | 317 / 502 |
ovary | 90% | 352.21 | 162 / 180 | 57% | 1.90 | 244 / 430 |
thymus | 93% | 417.23 | 606 / 653 | 38% | 0.74 | 227 / 605 |
pancreas | 95% | 828.80 | 311 / 328 | 4% | 0.07 | 7 / 178 |
lung | 79% | 169.34 | 458 / 578 | 19% | 0.39 | 223 / 1155 |
bladder | 76% | 140.24 | 16 / 21 | 13% | 0.35 | 66 / 504 |
stomach | 84% | 168.23 | 300 / 359 | 4% | 0.08 | 12 / 286 |
uterus | 34% | 44.43 | 58 / 170 | 26% | 0.53 | 118 / 459 |
esophagus | 46% | 52.43 | 658 / 1445 | 14% | 0.30 | 26 / 183 |
breast | 46% | 49.55 | 209 / 459 | 14% | 0.29 | 154 / 1118 |
blood vessel | 58% | 80.29 | 779 / 1335 | 0% | 0 | 0 / 0 |
skin | 42% | 125.09 | 761 / 1809 | 14% | 0.28 | 68 / 472 |
adipose | 54% | 70.05 | 651 / 1204 | 0% | 0 | 0 / 0 |
intestine | 45% | 45.04 | 439 / 966 | 3% | 0.05 | 17 / 527 |
heart | 46% | 46.03 | 397 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 36% | 0.75 | 16 / 45 |
kidney | 31% | 30.26 | 28 / 89 | 3% | 0.05 | 28 / 901 |
peripheral blood | 31% | 31.17 | 285 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 23% | 0.33 | 18 / 80 |
adrenal gland | 14% | 10.11 | 37 / 258 | 1% | 0.02 | 3 / 230 |
spleen | 12% | 9.51 | 28 / 241 | 0% | 0 | 0 / 0 |
muscle | 2% | 1.54 | 20 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010749 | Biological process | regulation of nitric oxide mediated signal transduction |
GO_0001974 | Biological process | blood vessel remodeling |
GO_0019346 | Biological process | transsulfuration |
GO_0019344 | Biological process | cysteine biosynthetic process |
GO_0001958 | Biological process | endochondral ossification |
GO_0097746 | Biological process | blood vessel diameter maintenance |
GO_0019343 | Biological process | cysteine biosynthetic process via cystathionine |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0006565 | Biological process | L-serine catabolic process |
GO_0042262 | Biological process | DNA protection |
GO_0070814 | Biological process | hydrogen sulfide biosynthetic process |
GO_0050667 | Biological process | homocysteine metabolic process |
GO_0051593 | Biological process | response to folic acid |
GO_0043418 | Biological process | homocysteine catabolic process |
GO_0021587 | Biological process | cerebellum morphogenesis |
GO_0019448 | Biological process | L-cysteine catabolic process |
GO_0006801 | Biological process | superoxide metabolic process |
GO_0060351 | Biological process | cartilage development involved in endochondral bone morphogenesis |
GO_0006535 | Biological process | cysteine biosynthetic process from serine |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0060135 | Biological process | maternal process involved in female pregnancy |
GO_0006563 | Biological process | L-serine metabolic process |
GO_0005634 | Cellular component | nucleus |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0019899 | Molecular function | enzyme binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0004122 | Molecular function | cystathionine beta-synthase activity |
GO_0030170 | Molecular function | pyridoxal phosphate binding |
GO_0070026 | Molecular function | nitric oxide binding |
GO_1904047 | Molecular function | S-adenosyl-L-methionine binding |
GO_0070025 | Molecular function | carbon monoxide binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0019825 | Molecular function | oxygen binding |
GO_0050421 | Molecular function | nitrite reductase (NO-forming) activity |
GO_0020037 | Molecular function | heme binding |
GO_0072341 | Molecular function | modified amino acid binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CBS |
Protein name | Cystathionine beta-synthase Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase) Cystathionine B synthase |
Synonyms | |
Description | FUNCTION: Hydro-lyase catalyzing the first step of the transsulfuration pathway, where the hydroxyl group of L-serine is displaced by L-homocysteine in a beta-replacement reaction to form L-cystathionine, the precursor of L-cysteine. This catabolic route allows the elimination of L-methionine and the toxic metabolite L-homocysteine . Also involved in the production of hydrogen sulfide, a gasotransmitter with signaling and cytoprotective effects on neurons (By similarity). . |
Accessions | ENST00000451248.5 ENST00000430013.1 Q5CCK6 C9JMA6 ENST00000441030.5 ENST00000352178.9 [P35520-1] H7C2W0 ENST00000458223.5 Q5CCK7 H7C2H4 ENST00000398158.5 [P35520-1] H7C1W6 ENST00000398165.8 [P35520-1] P35520 ENST00000359624.7 [P35520-1] |